(Q36611537)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17017544%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

review article

1 reference

title

Kynurenines, Parkinson's disease and other neurodegenerative disorders: preclinical and clinical studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17017544%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

1 reference

H Németh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17017544%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

J Toldi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17017544%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

L Vécsei

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17017544%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

language of work or name

1 reference

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17017544%20AND%20SRC:MED&resulttype=core&format=json

Journal of neural transmission. Supplementum

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17017544%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17017544%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

285-304

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17017544%20AND%20SRC:MED&resulttype=core&format=json

Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus.

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease--an in situ hybridization study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Systemically administered D-glucose conjugates of 7-chlorokynurenic acid are centrally available and exert anticonvulsant activity in rodents

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Kynurenine as an Intermediate in the Formation of Nicotinic Acid from Tryptophane by Neurospora

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Compensatory effects of glutamatergic inputs to the substantia nigra pars compacta in experimental parkinsonism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Presymptomatic revelation of experimental parkinsonism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Early effects of intrastriatal injections of quinolinic acid on microtubule-associated protein-2 and neuropeptides in rat basal ganglia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Effects of intrastriatal injection of quinolinic acid on electrical activity and extracellular ion concentrations in rat striatum in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Blockade of excitatory amino acid receptors protects anoxic hippocampal slices

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Glial-neuronal transfer of arginine and S-nitrosothiols in nitric oxide transmission.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Localization of kynurenine aminotransferase immunoreactivity in the rat hippocampus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Kynurenine pathway enzymes in a rat model of chronic epilepsy: immunohistochemical study of activated glial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Neurodegenerative diseases and oxidative stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

alpha-[11C]-Methyl-L-tryptophan PET identifies the epileptogenic tuber and correlates with interictal spike frequency

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Blood?Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Secreted amyloid precursor protein alpha selectively suppresses N-methyl-D-aspartate currents in hippocampal neurons: involvement of cyclic GMP.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Comparative study on the effects of kynurenic acid and glucosamine-kynurenic acid.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Synthesis and metabolism of L-kynurenine in rat brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Bioenergetics and glutamate excitotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

A beta 1-42 induces production of quinolinic acid by human macrophages and microglia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Quinolinic acid in the pathogenesis of Alzheimer's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Kynurenine metabolism in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Increased expression of cyclin-dependent kinase 5 in induced apoptotic neuron death in rat substantia nigra

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Developmental cell death in dopaminergic neurons of the substantia nigra of mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Microemulsions as colloidal vehicle systems for dermal drug delivery. Part IV: Investigation of microemulsion systems based on a eutectic mixture of lidocaine and prilocaine as the colloidal phase by dynamic light scattering

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Apoptotic neuron death in rat substantia nigra induced by striatal excitotoxic injury is developmentally dependent.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Glycine site antagonists abolish dopamine D2 but not D1 receptor mediated catalepsy in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Central role of hypothalamic digoxin in conscious perception, neuroimmunoendocrine integration, and coordination of cellular function: relation to hemispheric dominance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Hypothalamic digoxin--central role in conscious perception, neuroimmunoendocrine integration and coordination of cellular function--relation to hemispheric dominance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Hypothalamic digoxin-mediated model for Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Kynurenines as probable participants of depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Antagonism of kynurenic acid to anxiogens in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Excitotoxic injury stimulates pro-drug-induced 7-chlorokynurenate formation in the rat striatum in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Free radical pathways in CNS injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Convection-enhanced selective excitotoxic ablation of the neurons of the globus pallidus internus for treatment of parkinsonism in nonhuman primates

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Can the USP paddle method be used to represent in-vivo hydrodynamics?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Apoptosis in substantia nigra following developmental striatal excitotoxic injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Glutamate receptor subtypes mediate excitatory synaptic currents of dopamine neurons in midbrain slices

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

The non-NMDA glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline, but not NMDA antagonists, block the intrastriatal neurotoxic effect of MPP+.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Quinolinic acid lesion of the nigrostriatal pathway: effect on turning behaviour and protection by elevation of endogenous kynurenic acid in Rattus norvegicus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Presence of Kynurenic Acid in the Mammalian Brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Alpha-[11C] methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Kynurenine administered together with probenecid markedly inhibits pentylenetetrazol-induced seizures. An electrophysiological and behavioural study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Kynurenine pathway abnormalities in Parkinson's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Behavioral and anatomical effects of quinolinic acid in the striatum of the hemiparkinsonian rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Behavioral/neurophysiological investigation of effects of combining a quinolinic acid entopeduncular lesion with a fetal mesencephalic tissue transplant in striatum of the 6‐OHDA hemilesioned rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Kynurenine in blood plasma and DST in patients with endogenous anxiety and endogenous depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

The role of striatal glutamate receptors in models of Parkinson's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Quinolinic acid is a potent lipid peroxidant in rat brain homogenates

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Systemically administered glucosamine-kynurenic acid, but not pure kynurenic acid, is effective in decreasing the evoked activity in area CA1 of the rat hippocampus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Comparative analysis of superoxide dismutase activity between acute pharmacological models and a transgenic mouse model of Huntington's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Effect of systemic administration of L-kynurenine on corticocerebral blood flow under normal and ischemic conditions of the brain in conscious rabbits

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Electrophysiological effects of exogenous and endogenous kynurenic acid in the rat brain: studies in vivo and in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Pretreatment with L-kynurenine, the precursor to the excitatory amino acid antagonist kynurenic acid, suppresses epileptiform activity in combined entorhinal/hippocampal slices.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Seizure activity and lesions after intrahippocampal quinolinic acid injection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Differential vulnerability of central neurons of the rat to quinolinic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Prostaglandin-mediated control of rat brain kynurenic acid synthesis--opposite actions by COX-1 and COX-2 isoforms

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Micromolar Brain Levels of Kynurenic Acid are Associated with a Disruption of Auditory Sensory Gating in the Rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Endothelium-dependent production and liberation of kynurenic acid by rat aortic rings exposed to L-kynurenine.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Kynurenines in the CNS: from endogenous obscurity to therapeutic importance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Tryptophan metabolites and brain disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Movement disorder following excitotoxin lesions in primates

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

The cortical lesion of Huntington's disease: further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N-methyl-D-aspartate lesions of rat cortex

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal fluid of patients with Parkinson's disease, and their changes after L-dopa administration

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Concentrations of serotonin and its related substances in the cerebrospinal fluid of parkinsonian patients and their relations to the severity of symptoms

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Glutamatergic-receptors blockade does not regularize the slow wave sleep bursty pattern of subthalamic neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Influence of kynurenine treatment on open-field activity, elevated plus-maze, avoidance behaviors and seizures in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Intracerebroventricular injection of kynurenic acid, but not kynurenine, induces ataxia and stereotyped behavior in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Comparative behavioral and neurochemical studies with striatal kainic acid- or quinolinic acid-lesioned rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Comparative behavioral and pharmacological studies with centrally administered kynurenine and kynurenic acid in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Towards neurotransplantation in multiple system atrophy: clinical rationale, pathophysiological basis, and preliminary experimental evidence.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Neopterin production, tryptophan degradation, and mental depression--what is the link?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Increased neopterin production and tryptophan degradation in advanced Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Effect of systemic L-DOPA administration on extracellular kynurenate levels in the rat striatum

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Enzyme-catalyzed production of the neuroprotective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Excitatory amino acid-induced excitation of dopamine-containing neurons in the rat substantia nigra: modulation by kynurenic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Inhibitory glutamatergic regulation of evoked dopamine release in striatum

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

The carbonate radical anion-induced covalent aggregation of human copper, zinc superoxide dismutase, and alpha-synuclein: intermediacy of tryptophan- and tyrosine-derived oxidation products

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

Role of excitatory amino acids in the regulation of dopamine synthesis and release in the neostriatum.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-211-45295-0_45

10.1007/978-3-211-45295-0_45

31 March 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17017544%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference